Search results for: 'deep intelligent pharma'

This analysis brings to focus insights from the panel discussions conducted at Frost & Sullivan's two-day Intelligent Mobility virtual event held in September 2022. These include speeches from thought leaders from Frost & Sullivan's Mobility practice area and a host of other companies, such as Nissan, Foxconn, ZF, Navya, and so on. The entire works...

15 Sep 2022  |  Global  |  Market Research

Global Cyber Threat Intelligence (CTI) and Threat Intelligence Platform (TIP) Markets—Forecast to 2024

The Ever-evolving and Sophisticated Threat Landscape Fuels Demand for Threat Intelligence Solutions

Infographics

×

Threat intelligence is the collection, analysis, and operationalization of external and internal data about past, present, and future cyberattacks that organizations can leverage to understand their security environments and prevent threats. Frost & Sullivan identifies three segments in this broad market: cyber threat intelligence (CTI), threat...

As organizations shift critical workloads to public, private, and hybrid clouds, encrypted data flows and lateral traffic have created visibility gaps that traditional observability tools cannot close. Deep observability has emerged as a strategic imperative for CISOs seeking to eliminate these blind spots, unify telemetry data, and strengthen cybe...

This Frost & Sullivan research examines the growing need for artificial intelligence (AI) services to help businesses meet key goals and objectives, as well as the strategic position of public cloud service providers to develop and launch successful AI capabilities for customers. The report discusses the importance of public cloud providers in the ...

The biopharma industry has been evolving over the past few decades. This study analyses the top ten trends that will impact the future of the biopharma industry through 2040.The future of biopharma will be driven by innovation in AI and ML, particularly generative AI, and by advancements in translational medicine and synthetic biology. Future clini...

With the growing preference for a patient-centric care delivery approach, the pharma industry follows a robust step-by-step approach towards market commercialization, with a clear understanding of the market stakeholders, segments, as well as post-launch forecasts to create seamless go-to-market strategies. To cater to the ever-evolving market land...

The modern threat landscape has undergone a profound transformation, driven by the global push toward digitalization. This has led to expanded attack surfaces, heightened IT complexity, and increased risks in supply chains. Today, threat actors launch multivector attacks that target organizations internal networks and their external digital assets...

This study covers ongoing and planned deep space missions across government and commercial agencies and examines the opportunities they will create for the NewSpace and ICT market participants. The study categorizes the deep space missions across the following key segments: lander, rover, and orbiter. It identifies the evolving requirements of the ...

The pharmaceutical and biotechnology industries are entering a transformative era in 2025, shaped by a convergence of scientific innovation, regulatory evolution, and market pressures. One of the key imperatives is the continued advancement of therapeutics and drug approvals, as breakthrough treatments, particularly in personalized medicine, promis...